Potential treatments for epigenetic dysregulation in neurological diseases

Potential treatments for epigenetic dysregulation in neurological diseases

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Detalles Bibliográficos
Autor principal:	Zaman, Rubaiyat
Otros Autores:	Sharmin, Sabrina
Formato:	Tesis
Lenguaje:	English
Publicado:	Brac University 2024
Materias:	Epigenetics Methylation Parkinson’s disease Alzheimer’s disease Huntington’s disease Acetylation Nervous System Diseases Epigenesis
Acceso en línea:	http://hdl.handle.net/10361/23157

Ejemplares similares

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
por: Mostofa, Golam
Publicado: (2022)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
por: Dey, Manashi
Publicado: (2024)

Role of epigenetics in the development of metabolic disorders: a review
por: Mita, Tanzia Mohsin
Publicado: (2024)

Role of circular RNA in neurological disease
por: Salsabil, Labiba
Publicado: (2024)

Gene editing for neurodegenerative diseases-A review
por: Sharna, Anika Islam
Publicado: (2023)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
por: Alim, Abdul
Publicado: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
por: Annee, Israt Jahan
Publicado: (2023)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
por: Afsana, Nourin
Publicado: (2022)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
por: Chowdhury, Sariya Uzrat
Publicado: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
por: Ferdous, Labiba
Publicado: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
por: Bakar, Osama Bin Abu
Publicado: (2024)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
por: Tabassum, Nadira
Publicado: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
por: Islam, Md. Irfath
Publicado: (2023)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
por: Shehab, Habibul Mohsin
Publicado: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
por: Afreen, Nuraia
Publicado: (2021)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
por: Karmaker, Swastika
Publicado: (2024)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
por: Key, Nasrin Sultana
Publicado: (2023)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
por: Tamanna, Mst. Taskia
Publicado: (2023)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
por: Tasneem, Sadia
Publicado: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
por: Ishrat, Nowshin
Publicado: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
por: Saha, Bithi Rani
Publicado: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
por: Chowdhury, Amal
Publicado: (2024)

A review on cardiovascular development and epigenetics
por: Srity, Nafisa Alam
Publicado: (2024)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
por: Hassan, Md. Muhtaz
Publicado: (2020)

Marine compounds in the treatment of Alzheimer’s disease
por: Parveen, Sanjana
Publicado: (2022)

Alzheimer's disease and marriage : an intimate account /
por: Wright, Lore K.
Publicado: (1993)

Review on: the mechanism and function of Glia in parkinson's disease
por: Abedin, Khondokar Mezbahul
Publicado: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
por: Tasin, Md Abtahi
Publicado: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
por: Aziz, Farhin
Publicado: (2019)

Infection and communicable diseases /
por: Brettle, Raymond Patrick
Publicado: (1984)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
por: Afra, Sumaiya
Publicado: (2022)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
por: Mahee, Sadique Abdal
Publicado: (2024)

Early detection of parkinson’s disease using image processing and artificial neural network
por: Rumman, Mosarrat, et al.
Publicado: (2018)

Cerebrovascular and neurological dysfunction as a result of COVID-19 infection in patients with migraine
por: Rawshan, A. E. Maisha
Publicado: (2022)

A study on less explored plants with potential neuroprotective activity against neurodegenerative diseases
por: Nayeem, Abdullah Al
Publicado: (2021)

Control of communicable diseases manual : an official report of the American Public Health Association /
Publicado: (1995)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
por: Islam, Md. Rakibul
Publicado: (2023)

Clinical Infectious Diseases

The Journal of Infectious Diseases

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
por: Halim, Rabea
Publicado: (2022)